Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Osteoarthritis Knee Pain
NCT01518257Phase 2Completed
- Sponsor
- Allergan
- Start
- Jan 2012
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of onabotulinumtoxinA in osteoarthritis (OA), sponsored by Allergan. Started Jan 2012; status: completed.
02
Drugs
onabotulinumtoxinA
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01518257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518257.